Prashant Dongre

Title: Prashant Dongre: Innovator in Topical Formulations

Introduction

Prashant Dongre is a notable inventor based in Mumbai, India. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of stable topical treatments for acne. His innovative work has the potential to improve the quality of life for many individuals suffering from skin conditions.

Latest Patents

Prashant Dongre holds a patent for a stable fixed dose topical formulation. This invention relates to formulations that comprise an anti-acne agent and an antibiotic, which exhibit storage stability at a temperature of about 40°C and relative humidity of about 75% for a period of at least three months. The formulation specifically includes therapeutically effective amounts of adapalene-containing microspheres and clindamycin, along with a process for their preparation and use in treating acne. He has 1 patent to his name.

Career Highlights

Prashant Dongre is currently associated with Glenmark Pharmaceuticals Limited, a leading global pharmaceutical company. His work at Glenmark focuses on developing innovative solutions that address various health challenges. His expertise in formulation science has been instrumental in advancing the company's product offerings.

Collaborations

Prashant has collaborated with several professionals in his field, including Ulhas R Dhuppad and Nitin Babulal Bhamre. These collaborations have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking solutions.

Conclusion

Prashant Dongre's contributions to the field of topical formulations exemplify the impact of innovation in healthcare. His patent for a stable fixed dose topical formulation showcases his commitment to improving treatment options for acne. Through his work at Glenmark Pharmaceuticals Limited, he continues to push the boundaries of pharmaceutical science.